Now available, Atrial Fibrillation video ...
- cause of the disease
- risk factors and prevention
- variations by geography or ethnicity
- key co morbid conditions associated with the disease
- disease prognosis and clinical course
A real benefit of using the Epiomic patient segmentation database as a source is its ability to look beyond just the prevalence and incidence rate of a disease, and show clinically relevant sub-populations. These sub-populations can be either key co-morbid conditions or other clinical attributes that help size potential target populations of interest for drug development. All of these sub-populations are included in table format with each population segmented even further by country or other parameters related to the sub-population.
These reports are based on data and information sourced from the Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources to provide the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been cited in the report.